ResMed (RMD) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter was lower than the immediately preceding quarter. Compared with the same quarter one year earlier, revenue was higher.
Key takeaway
Quarter ended Sep 30, 2023 · FY2024 Q1
Revenue for the quarter was lower than the immediately preceding quarter. Compared with the same quarter one year earlier, revenue was higher.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
-1.8%
Change from the immediately preceding quarter.
Year-over-year
+16.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $1B | +15.5% |
| Mar 31, 2023 | $1.1B | +29.2% |
| Jun 30, 2023 | $1.1B | +22.7% |
| Sep 30, 2023 | $1.1B | +16.0% |
Revenue performance
The reported revenue declined from the prior quarter, reflecting a sequential decrease. On a year-over-year basis, revenue increased compared to the same period last year.
Quarterly comparison
Revenue in this quarter was lower than the immediately preceding quarter. Compared to the same quarter one year earlier, revenue was higher.
What to watch
The sequential decline in revenue may warrant attention in the context of prior growth trends.